跳至主要内容
临床试验/NCT04361630
NCT04361630已完成早期 1 期

Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Absorbable Collagen Membrane With Coronally Advanced Flap In Class I And II Gingival Recession Defects -A Randomized Control Trial

SVS Institute of Dental Sciences1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
30
试验地点
1
主要终点
Width of keratinized gingiva (wKG)

研究概览

简要总结

This study was a single-arm trial to obtain preliminary data on the efficacy of collagen membranes impregnated with recombinant human fibroblast growth factor (rhFGF-2) in the treatment of Miller's class I and class II gingival recessions.

详细描述

Soft tissues can be regenerated to cover root exposure and a thin biotype can be converted into a thick biotype by using recombinant human growth factor technology. A recent review stated that growth factors could enhance soft tissue regeneration which includes restoration of mucogingival architecture and regeneration of periodontal hard and soft tissues including bone, cementum and periodontal ligament fibers. Fibroblast growth factor-2 (FGF-2), a heparin-binding cytokine with strong angiogenic activity stimulates the proliferation of undifferentiated mesenchymal cells. These functions can be applied in mucogingival surgery as FGF-2 promotes bone and cementum formation and exhibits an increased potential to promote periodontal regeneration in recession defects.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

盲法说明

Single Blinded trial.

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • systemically healthy subjects between 20-55 years presenting with Miller's class I or class II gingival recession[

排除标准

  • Recessions associated with root demineralization/caries, deep cervical abrasion or pulpal pathology,
  • Patients with history of systemic conditions affecting periodontium and,

研究组 & 干预措施

Main treatment group

Experimental

Collagen membranes incorporating 10ng/ml human recombinant basic fibroblast growth factor (FGF-2/bFGF) will be placed in the sites.

干预措施: FGF 2 (Drug)

结局指标

主要结局

Width of keratinized gingiva (wKG)

时间窗: 5 months

To assess the wKG, the mucogingival junction was identified visually as the border between the movable (alveolar mucosa) and immovable tissue (gingiva). The distance from the gingival margin to the mucogingival junction was considered as the Wkg.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr R Viswa Chandra

Primary Investigator

SVS Institute of Dental Sciences

研究点 (1)

Loading locations...

相似试验